Select Biotechnolgy PortFBIOX
13F holders, Q4 2025 (December 31)2holders
0new positions
0sold out
$23.64avg. 13F price*
At the end of Q4 2025, 2 institutions reported holding Select Biotechnolgy Port (FBIOX) in their 13F filings, unchanged from Q3 2025. 0 opened new positions and 0 sold out. The largest holders were Financial Gravity Asset Management, Inc. ($12K) and Coston, McIsaac & Partners ($1K).
- Company
- Select Biotechnolgy Port
- Filed as
- FIDELITY SELECT BIOTECHNOLOGY (Q4 2025)
- CUSIP
- 316390772
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q3 2025 → Q4 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 0 | $0 |
All 13F filers, Q3 2025 → Q4 2025: 10 shares bought and 21 shares sold, net −11 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 2 holders
| Financial Gravity Asset Management, Inc. | 0.00% | Add +2.1% | 487 | $12K |
| Coston, McIsaac & Partners | 0.00% | Reduce -22.3% | 73 | $1K |
"% of holder's portfolio" is FBIOX's weight in each manager's 13F, not the share of Select Biotechnolgy Port the manager owns.